Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma

PURPOSE: To establish the efficacy and safety of intravitreal bevacizumab in reducing iris and anterior chamber angle neovascularization and managing neovascular glaucoma. DESIGN: Prospective interventional case series. PATIENT AND METHODS: Eleven eyes of 11 patients with iris and anterior chamber a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouzas, Dimitrios, Charakidas, Antonios, Moschos, Marilita, Koutsandrea, Chryssanthi, Apostolopoulos, Michael, Baltatzis, Stefanos
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801638/
https://www.ncbi.nlm.nih.gov/pubmed/20054417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801638/
https://www.ncbi.nlm.nih.gov/pubmed/20054417

Ejemplares similares